Editorial: Role of hypoxia-inducible factors in metabolic immune cell adaptation during sepsis

Editorial: Role of hypoxia-inducible factors in metabolic immune cell adaptation during sepsis

Bibliographic Details
Main Authors:	Carlos del Fresno, Leon Nicolas Schulte, Eduardo López-Collazo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Immunology
Subjects:	HIF sepsis metabolism myeloid cells inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1194504/full

Similar Items

The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsisResearch in context
by: Roberto Lozano-Rodríguez, et al.
Published: (2023-11-01)

Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy
by: Athanasios I. Lourbopoulos, et al.
Published: (2021-12-01)

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction
by: Rabina Mainali, et al.
Published: (2021-02-01)

Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
by: Ilias Mylonis, et al.
Published: (2019-03-01)

Hypoxia Inducible Factor as a Central Regulator of Metabolism – Implications for the Development of Obesity
by: Joana M. Gaspar, et al.
Published: (2018-11-01)

HIF1α-dependent hypoxia response in myeloid cells requires IRE1α
by: Gaëlle Mawambo, et al.
Published: (2023-06-01)

The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism
by: Xiu Lv, et al.
Published: (2017-03-01)

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
by: Lise Van Wyngene, et al.
Published: (2018-08-01)

Immunometabolism and Sepsis: A Role for HIF?
by: Susan F. Fitzpatrick
Published: (2019-09-01)

Hypoxia and Hypoxia-Inducible Factors in Lymphedema
by: Xinguo Jiang, et al.
Published: (2022-03-01)

The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease
by: Evelyn L. Kerber, et al.
Published: (2020-11-01)

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
by: Chie Ogawa, et al.
Published: (2023-02-01)

Hypoxia-Modified Cancer Cell Metabolism
by: Wafaa Al Tameemi, et al.
Published: (2019-01-01)

Adaptive Cardiac Metabolism Under Chronic Hypoxia: Mechanism and Clinical Implications
by: Zhanhao Su, et al.
Published: (2021-02-01)

Breast cancer cells and adipocytes in hypoxia: metabolism regulation
by: Xin Yu, et al.
Published: (2024-01-01)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
by: Margaret A. McBride, et al.
Published: (2021-02-01)

Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension
by: Yi Ye, et al.
Published: (2023-05-01)

Ethyl pyruvate protects against sepsis by regulating energy metabolism
by: Kang H, et al.
Published: (2016-02-01)

Editorial: Immune regulation in sepsis
by: Huiling Zhang, et al.
Published: (2023-10-01)

Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
by: Bernadette M. M. Zwaans, et al.
Published: (2014-09-01)

Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis
by: Nan Lin, et al.
Published: (2018-11-01)

The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma
by: Margaret A. McBride, et al.
Published: (2020-05-01)

A hypoxia- and lactate metabolism-related gene signature to predict prognosis of sepsis: discovery and validation in independent cohorts
by: Yaojun Peng, et al.
Published: (2023-09-01)

Impact of norepinephrine on immunity and oxidative metabolism in sepsis
by: Joby Thoppil, et al.
Published: (2023-11-01)

Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis
by: Christina Nedeva
Published: (2021-07-01)

Adaptive strategies of aquatic mammals: Exploring the role of the HIF pathway and hypoxia tolerance
by: Yuri Yépez, et al.
Published: (2024-01-01)

Regulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines
by: Mykyta I. Malkov, et al.
Published: (2021-09-01)

Metabolic Reprogramming and Host Tolerance: A Novel Concept to Understand Sepsis-Associated AKI
by: Juan Toro, et al.
Published: (2021-09-01)

Swertianolin ameliorates immune dysfunction in sepsis <em>via</em> blocking the immunosuppressive function of myeloid- derived suppressor cells
by: Zongfang Ren, et al.
Published: (2021-09-01)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
by: Jonathan M. Hazlehurst, et al.
Published: (2022-06-01)

HIF-1α/BNIP3L induced cognitive deficits in a mouse model of sepsis-associated encephalopathy
by: Lina Zhao, et al.
Published: (2022-12-01)

Thiosulfinate-Enriched <i>Allium sativum</i> Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α
by: José Avendaño-Ortiz, et al.
Published: (2023-03-01)

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
by: Vittoria Infantino, et al.
Published: (2021-05-01)

Metabolic Alterations in Sepsis
by: Weronika Wasyluk, et al.
Published: (2021-05-01)

The role of hypoxia-inducible factors in the development of chronic pathology
by: N. S. Shevchenko, et al.
Published: (2021-08-01)

Dysregulated Immunity and Immunotherapy after Sepsis
by: Dijoia B. Darden, et al.
Published: (2021-04-01)

Prognostic Value of HIF-1α-Induced Genes in Sepsis/Septic Shock
by: Nikolaos S. Lotsios, et al.
Published: (2023-06-01)

The Role of Hypoxia-Inducible Factor Isoforms in Breast Cancer and Perspectives on Their Inhibition in Therapy
by: Karolina Kozal, et al.
Published: (2022-09-01)

The lipid biology of sepsis
by: Kaushalya Amunugama, et al.
Published: (2021-01-01)

PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
by: Wasyluk W, et al.
Published: (2021-05-01)